SOTHEMA stock price and financial data
Invest with RicherFin and research the stock. SOTHEMA (SOT), CSE : share price and history, results and fundamentals, company publications, analysis tools and peer companies.
An investment account is required to buy shares. Demo mode uses virtual money: no order is sent to the market.
Price history
Issuer profile
Sothema is a Moroccan pharmaceutical company specializing in the production, marketing and distribution of medicines. It manufactures products in forms such as tablets, capsules, syrups, ampoules, creams, ointments, powders and injectable suspensions. The company also manufactures under license or subcontracting arrangements for Moroccan and international laboratories and participates in export markets across Europe and Africa. Its business model depends on pharmaceutical manufacturing quality, regulatory approvals, product portfolio breadth, laboratory partnerships, distribution access and demand from healthcare providers and pharmacies. Key business drivers include customer demand, pricing discipline, operating efficiency, distribution reach and access to financing.
Fundamentals
connect to view moreSign in to unlock the full fundamentals history.
Sign in| Metric (MAD, B) | 2024 2024 | 2023 2023 | 2022 2022 | 2021 2021 | 2020 2020 |
|---|---|---|---|---|---|
| Revenue Total Revenue | 2.82 | ||||
| EBITDA | 0.57 | ||||
| EBIT | 0.53 | ||||
| Net income Net Income | 0.32 | ||||
| Net margin | 11.2% |